Exelixis reported $19.98M in Trade Creditors for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Acadia Pharmaceuticals ACAD:US $ 11.85M 1.09M
Agios Pharmaceuticals AGIO:US $ 7.79M 3.76M
Akebia Therapeutics AKBA:US $ 24.94M 5.48M
Amgen AMGN:US $ 1256M 147M
Bayer BAYN:GR 6.1B 250M
Bluebird Bio BLUE:US $ 24.86M 3.48M
Bristol Myers Squibb BMY:US $ 2882M 62M
Cytokinetics CYTK:US $ 14.08M 5.76M
Eisai 4523:JP Y 96106M 66475M
Eli Lilly And LLY:US $ 1659.3M 226M
Esperion Therapeutics ESPR:US $ 12.83M 14M
Exelixis EXEL:US $ 19.98M 2.69M
Macrogenics MGNX:US $ 2.61M 1.12M
Mirati Therapeutics MRTX:US $ 24.27M 3.67M
Moderna Inc MRNA:US 181M 18M
Nektar Therapeutics NKTR:US $ 12.35M 0.27M
Novartis NOVN:VX 4.97B 114M
Puma Biotechnology PBYI:US $ 9.84M 2.43M
Seattle Genetics SGEN:US $ 128.87M 41.64M
Takeda 4502:JP Y 424358M 91939M
Ultragenyx Pharmaceutical RARE:US $ 34.21M 10.53M
Xencor XNCR:US $ 15.75M 3.84M
YTE INCY:US $ 194.77M 42.22M